Home > Insider Trading > Filing (0000313143-11-000032)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
313143	Haemonetics Corp	HAE	Surgical & Medical Instruments & Apparatus (3841)	042882273

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1266051	J Christopher Lindop	400 Wood Road Braintree MA 02184	Cfo &Amp Vice President Of	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-05-04	273	$46.80	11,370	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Non-Qualified Stock Option (right to buy)	$48.09	2008-01-25	2014-01-25	40,545	40,545	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$51.07	2008-10-24	2014-10-24	21,238	21,238	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$52.63	2009-10-23	2015-10-23	49,020	49,020	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$52.94	2010-10-27	2016-10-27	22,036	22,036	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$54.55	2009-10-22	2015-10-22	21,441	21,441	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$54.99	2011-10-27	2017-10-27	25,095	25,095	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2014-01-25	40,545	40,545	Direct
2014-10-24	21,238	21,238	Direct
2015-10-23	49,020	49,020	Direct
2016-10-27	22,036	22,036	Direct
2015-10-22	21,441	21,441	Direct
2017-10-27	25,095	25,095	Direct

Footnotes

Acquisition of shares of Common Stock pursuant to the Employee Stock Purchase Plan. Participant elected to purchase shares at least six months in advance of the effective date of the transaction.
Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
Grant to reporting person of right to buy shares of common stock vesting in annual increments over a 5 year period beginning on the first anniversary of the date of grant.